A Two-Phase, Dose-Ranging, Placebo-Controlled Study of the Safety and Preliminary Test of Acute Effects of Oral Δ 8 -Tetrahydrocannabivarin in Healthy Participants
This small two-phase trial tested single oral doses of the Δ8 form of THCV (placebo and 12.5, 25, 50, 100, 200 mg) in healthy adults and followed participants for up to 8 hours. Most side effects were mild, some doses showed a possible short-term improvement in a sustained-attention test, and…